nach oben

Erschienen in:

01.11.2016 | Case report

Trastuzumab emtansine

First report of atypical corneal lesions: case report

Einloggen, um Zugang zu erhalten

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is:

…

Tsuda M, et al. Abnormal corneal lesions induced by trastuzumab emtansine: An antibody-drug conjugate for breast cancer. Cornea 35: 1378-1380, No. 10, Oct 2016. Available from: URL: http://doi.org/10.1097/ICO.0000000000000868 - JapanCrossRefPubMed

Titel: Trastuzumab emtansine
First report of atypical corneal lesions: case report
Publikationsdatum: 01.11.2016
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-22890-3